Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Wireless Monitoring Saves Time, May Save Lives

Continuous wireless monitoring reduced in-hospital complications and mortality in an Italian pilot trial and significantly eased nursing workload.

Guideline Offers Holistic View of Brain-Heart Comorbidities

The aim of the new guideline is to expand on current cardiovascular guidelines to include evidence from the neurologic and mental health literature.

Goodbye, Prediabetes, Hello, Type 2 Diabetes Stages?

Leaders in the diabetes field are proposing eliminating the prediabetes label in favor of type 2 diabetes stages.

TAVR Embolic Protection Devices Go Head to Head: PROTECT H2H

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the role of these devices remains unresolved.

Vascular Complications Tied to Poor CRC Outcomes in Diabetes

In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality.


Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Todays Updates

Brexpiprazole Safe, Effective in Early-Episode Schizophrenia

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients with early-episode schizophrenia, new research shows.

Oncology Care Model’s Net Losses Well Exceed Savings

But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say.

Latest News

Continuous wireless monitoring reduced in-hospital complications and mortality in an Italian pilot trial and significantly eased nursing workload.

The aim of the new guideline is to expand on current cardiovascular guidelines to include evidence from the neurologic and mental health literature.

Leaders in the diabetes field are proposing eliminating the prediabetes label in favor of type 2 diabetes stages.

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the role of these devices remains unresolved.

In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality.

News All Time

AI Tool Predicts LDL Without Direct Testing

A machine learning model predicts low-density lipoprotein cholesterol from routine lab data, offering a low-cost way to identify high-risk patients.

From Prediabetes to CVD in 20 Years: The Risk Gets Real

People with impaired fasting glucose levels face a higher risk for cardiovascular diseases and the onset of diabetes than those with normal fasting glucose levels.

Sleeve Gastrectomy Tied to Improved Vascular Markers

After sleeve gastrectomy, carotid intima-media thickness and multiple inflammatory, lipid, oxidative, and fibrinolytic markers decline, with oxidized LDL levels predicting carotid thickening.

Proposed Act Would Fill Gaps in Cancer Survivorship Care

If passed, the Comprehensive Cancer Survivorship Act would establish a national standard of care for cancer survivors.

Low-Dose Aspirin Underutilized as Preeclampsia Prevention

Women at high risk for preeclampsia often do not receive recommended preventive treatment.

Even Low HIV Load Can Double Heart Disease Risk

Low HIV viral load appears to raise the risk for new cardiovascular events in people with HIV, indicating the need for tailored prevention and testing of novel interventions.

EU Widens Access for Rare Lipid and Obesity Disorders

The European Medicines Agency has backed wider use of treatments for rare cholesterol and obesity disorders, offering new hope for adult and pediatric patients with limited options.

Health Risk May Vary by Alcohol Type

Beer, cider, and spirits are more harmful than wine at low-to-moderate consumption levels.

PCI Reduces Symptoms of Chronic Total Occlusion

A small carefully constructed and blinded clinical trial confirms that percutaneous intervention significantly relieves angina in patients with chronic total obstruction.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Extensive Screen Time Tied to CV Risk

Screen time is identified as an independent cardiovascular risk factor in an observational study of young adults living in Pakistan.

When Self-Reflection Becomes a Physician’s Enemy

Medical training makes self-examination a core virtue. But for many physicians, a habit meant to promote growth can quietly curdle into something damaging.

Knowledge Areas: Transforming Hospital Care

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by 12%, and in-hospital mortality by 48% — early but promising.

Recommended News For You

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

A garden can save your life

EVP Beats Cisplatin for Resectable MIBC

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Does pollution cause cancer?

Recommended Articles For You

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma? 

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options  

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy 

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In prostate cancer survivorship, sleep disturbances are underappreciated.

2.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

3.

Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer

4.

No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire

5.

It Is Cancer in Kate Middleton.

1.

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology

2.

Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding

3.

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer

4.

Unlocking the Immune Arsenal: A Revolution in Cancer Treatment

5.

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

2.

Current Scenario of Cancer- The Incidence of Cancer in Men

3.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

4.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot